Nektar Therapeutics (NKTR) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Nektar Therapeutics

    NASDAQ: NKTR · Real-Time Price · USD
    40.18
    4.20 (11.67%)
    At close: Sep 05, 2025, 3:59 PM
    40.30
    0.30%
    After-hours: Sep 05, 2025, 06:17 PM EDT

    Nektar Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -1.61 -0.39 -1.15 -4.73
    PEG Ratio
    		 0.03 0.01 0.04 -0.32
    PS Ratio
    		 1.94 1.19 4.59 24.30
    PB Ratio
    		 3.15 0.82 1.15 3.64
    P/FCF Ratio
    		 -1.08 -0.56 -1.37 -5.79
    P/OCF Ratio
    		 -1.09 -0.56 -1.39 -6
    OCF/S Ratio
    		 -1.79 -2.14 -3.3 -4.05
    Debt / Equity Ratio
    		 1.69 0.90 0.36 0.21
    Quick Ratio
    		 4.26 6.14 7.72 9.15
    Current Ratio
    		 4.26 6.45 8.00 9.34
    Asset Turnover
    		 0.32 0.23 0.13 0.09
    Interest Coverage
    		 -3.74 -5.42 -8.31 -9.43
    Return on Equity
    		 -1.96 -2.11 -1 -0.77
    Return on Assets
    		 -0.39 -0.69 -0.52 -0.47
    Return on Invested Capital
    		 -0.4 -0.36 -0.36 -0.42
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.69 0.59 0.76 0.76
    Net Profit Margin
    		 -1.21 -3.06 -4 -5.14
    Pretax Profit Margin
    		 -1.21 -3.07 -3.96 -5.13
    Operating Profit Margin
    		 -1.07 -1.52 -2.61 -4.38
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 -0.88 -2.7 -3.52 -4.54

    Add to Watchlist